MedPath

A clinical study to study the effect of drug VAEPPAM PATTAI KUDINEER for THANDAGA VATHAM(Lumbar Spodylosis)

Phase 2
Recruiting
Conditions
THANDAGA VATHAM
Registration Number
CTRI/2018/03/012818
Lead Sponsor
Dr S NEELAVATHI MD PhD
Brief Summary

The study is A Prospective Open Labelled Phase II Randomized clinical study to evaluate the therapeutic efficacy of VAEPPAM PATTAI KUDINEER 50ml BD for 30 days in 40 patients during the trial period of 12 months that will be conducted in Govt Siddha Medical College and Hospital Palayamkottai Tirunelveli Tamilnadu The primary outcome will be the therapeutic efficacy of trial drug VAEPPAM PATTAI KUDINEER for THANDAGA VATHAM The secondary outcome will be the evaluation of Siddha diagnostic parameters Safety of trial drug Pharmacological and Biochemical analysis of trial drug

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
All
Target Recruitment
40
Inclusion Criteria

Patients having symptoms of low back ache radiating to buttocks and lower limbs Pain aggrevated by forward bending Numbness in the lower extremities.

Exclusion Criteria

Patients with Systemic Hypertension Diabetes mellitus Cardiac disease Autoimmune diseases like Rheumatoid arthritis SLE Psoriasis Congenital spinovertebral deformities Liver disease Pregnancy and lactating mother Renal diseases Tuberculosis in spine.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Therapeutic efficacy of trial drug Vaeppam Pattai Kudineer for Thandaga Vatham30days
Secondary Outcome Measures
NameTimeMethod
Evaluation of Siddha diagnostic parameters Safety of trial drug Pharmacological and Biochemical analysis of trial drug30 days

Trial Locations

Locations (1)

Government Siddha Medical College and hospital

🇮🇳

Tirunelveli, TAMIL NADU, India

Government Siddha Medical College and hospital
🇮🇳Tirunelveli, TAMIL NADU, India
JENSIN BRINTHA L
Principal investigator
8056685300
ljbrintha@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.